Affiliated to Jawaharlal Nehru Technological University Anantapur (JNTUA)
Accorded 2 (f) & 12 (B) status by UGC
NBA (UG) and NAAC Accredited Institution

Poison and Drug Information Centre (PDIC)

Poison & Drug Information Center (PDIC)



We invite the poison or drug information specialists to give a short note on the potential services they provide and how it is helpful to the healthcare. We could include those experiences in the upcoming issues of the bulletin to strengthen the services of poison or drug information specialists.

Vision & Mission

  1. To improve the use of poison and drug information in clinical practice.
  2. To practice evidence based medicine.
  3. To improve quality of Pharm.D and Pharmacy Practice education.
  4. To publish on clinical information & Pharm.D education.



Chief Editor

Dr. Y. Padmanabha Reddy, Principal, RIPER & President, ISPOR India – Andhra

Pradesh Chapter


Mr. Dixon Thomas, Head, Dept. of Pharmacy Practice, RIPER & President-elect,

ISPOR India – Andhra Pradesh Chapter

Associate Editors

Dr. Adepu Ramesh, Professor, JSS University, Mysore

Dr. Gerardo Alvarez-Uria, Head, Dept. of Infectious Diseases, RDT Hospital

Dr. P. Selvam, Research Director & Professor, RIPER

Dr. C. Sowmya, Professor, RIPER

Dr. P. Ramalingam, Professor, RIPER

Dr. Jyothi MV, Professor, RIPER

Mrs. Seeba Zachariah, Assoc Professor, RIPER, Secretary, ISPOR AP Chapter

Dr. S. Sriram, Professor, SRIPMS, Coimbatore

Dr. Roger Walker, Chief Pharmaceutical Officer, Wales, U.K.

Dr. Chris Wisniewski, MUSC Drug Information Center, USA

Ms. Atefa Noorain, Associate Research analyst, Thomson Reuters, Hyderabad

Editorial Advisory Board

Dr. M.S. Kannan, Medical Director, RDT Hospital & Director, ISPOR AP Chapter

Dr. A.N. Nagappa, Professor, Manipal University, Karnataka

Dr. G.P. Mohanta, Professor, Annamalai Univeristy, T.N.

Dr. Gayathri Palat, Program Director, Palliative Access (PAX) Programme, India

Dr. C. Vijaya Raghavan, Vice-Principal, PSG College of Pharmacy, T.N.

Dr. Subhash C. Mandal, Vice President, IPA-Bengal Branch

Dr. Sunil K Jain, Chief Pharmacist, AIIMS, New Delhi

Dr. B. J. Mahendra Kumar, Prof, JDT Islam College of Pharmacy, Kerala

Dr. Gunasakaran, Clinical Head, Azidus Laboratory Ltd, T.N.

Dr. S.S. Rao, Pharmacist, Canada

Mr. Ali Dulfikkar, Pharmacist, Dubai

Prof. M.N. Femi Oyewo, Olabisi Onabanjo University, Nigeria

Dr. Ugochi Nyere Ogudu, Lagos Island Maternity Hospital, Nigeria

Dr. Azubike Okwor, President, Pharmaceutical Association of Nigeria

Dr. Cheikh Saad, Univeristy of Thies, Senegal

Dr. Stein Lyftingsmo, Pharmacist, Norway

Dr. M.K. Unnikrishnan, Professor, Manipal University, Karnataka

Mr. Sonal Sekhar, Sr. Lecturer, Manipal University, Karnataka

Dr. Hari Hara Nadha Sarma, Medical Superintendent, RDT Hospital, Bathalapalli

Dr. H. Harish, Head, Dept. of Anesthesia RDT Hospital, Bathalapalli

Dr. Tadepalli Durgesh, Head, Children’s Hospital, RDT Hospital, Bathalapalli

Dr. K. Sudheer Kumar, Head, Dept. of Surgery, RDT Hospital, Bathalapalli

Dr. Alexander Daniel Sunad, Surgeon, RDT Hospital & Director, ISPOR AP Chapter

Mr. K. Thejomoorthy, Chief Pharmacist, RDT Hospital

Mr. Prasanth Kumar, Data Manager, Novartis Healthcare Pvt. Ltd.

Mr. Tapan Kumar Shah, Clinical Operations, Boehringer Ingelheim India Pvt. Ltd

Dr. Baghavan PS, Registrar, Karnataka Pharmacy Council

Dr. Tarun Wadhwa, Asst Professor, KLE College of Pharmacy, Belgaum


Instruction to the authors

  1. Please send your articles to riperdruginfo@gmail.com or isporap@gmail.com
  2. All correspondence would be through email. Please send the novel article related to therapeutics, drug or poison informatics, pharmacy practice / clinical practice, research, clinical nutrition, bed side teaching, clinical education etc.
  3. Please contribute your articles in A4, Arial font size 12, single spacing, please give the references cited in the text with Arabic numerals as superscripts;
  4. Original research (not more than 5 pages)
  5. Review (not more than 5 pages)
  6. Short communication (not more than 2 pages)
  7. View point / message (not more than 2 pages)
  8. Proceedings of conference / seminar (not more than 3 pages)
  9. The article will undergo peer review process. Once it is accepted for publication, do the corrections if necessary and a copyright letter with the following wordings to be send as an e-mail to the editor within 5 days.
  10. “The article titled as………………………………………… by the ……………………………………………………………………… (authors) is not send elsewhere for publication or is not published previously or not under consideration for publication other than RIPER PDIC Bulletin. Here we transfer the complete copyright of the article to publish or reproduce to RIPER PDIC Bulletin. The above mentioned article is plagiarism free. I the corresponding author have the right to sign the copyright transfer form on behalf of all the contributing authors.” Please describe in your own words if any conflict of interest exists. Editorial board holds the right to do the necessary editing as part of final editing.
  11. Corresponding author …………………………………… (Name & Sign with date).